Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Vitrafy Life Sciences Ltd (ASX:VFY, OTC:VFYLF) has partnered with major US blood network Versiti Blood Health to advance development of its cryopreservation ecosystem for platelets while supporting the company’s planned US medical device listing. The partnership builds on Vitrafy’s Phase II...
Vitrafy Life Sciences Ltd (ASX:VFY) reports strong cash position and strategic partnerships as it scales manufacturing and prepares for FDA clearance.
Vitrafy Life Sciences Ltd (ASX:VFY, OTC:VFYLF) is raising A$30 million in an institutional placement, which will give it fresh capital to expand manufacturing capacity and accelerate commercial growth in the United States following recent progress in the US blood market. The placement was...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.